Publications, Dec 2012

• Hawton A, Green C, Telford C, Zajicek J, Wright D. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. Value Health 2012 Dec;15(8):1084-91.
• Lu L, Pearce H, Roome C, Shearer J, Lang IA, Stein K. Cost effectiveness of oromucosal cannabis-based medicine (sativex(R)) for spasticity in multiple sclerosis. PharmacoEconomics 2012 Dec;30(12):1157-71.

Date: 31 December 2012